Advertisement

Topics

New three-in-one blood test opens door to precision medicine for prostate cancer

20:01 EDT 18 Jun 2017 | ecancermedicalscience

Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes. This follows last week's announcement of a blood test for...

Original Article: New three-in-one blood test opens door to precision medicine for prostate cancer

NEXT ARTICLE

More From BioPortfolio on "New three-in-one blood test opens door to precision medicine for prostate cancer"

Quick Search
Advertisement